Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola Valeri

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Plos One|May 19, 2012
rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancerBríd M Ryan, Andrew C McClary, Nicola Valeri, et al.
Non-Coding RNA Research|December 12, 2018
LONG-NONCODING RNAs in gastroesophageal cancersGiuseppe Nicolò Fanelli, Pierluigi Gasparini, Irene Coati, et al.
Virchows Archiv : an International Journal of Pathology|December 23, 2023
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reportingFederica Grillo, Valentina Angerilli, Paola Parente, et al.
Clinical Colorectal Cancer|November 9, 2018
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center ExperienceKhurum Khan, Jayant K Rane, David Cunningham, et al.
Stem Cell Reports|January 20, 2023
USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor developmentLaura Novellasdemunt, Anna Kucharska, Anna Baulies, et al.
Oncotarget|December 25, 2015
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesisMatteo Fassan, Deborah Saraggi, Laura Balsamo, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 5, 2026
Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Nicola Valeri, Pierluigi Gasparini, Chiara Braconi, et al.
Histopathology|February 22, 2018
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trialNasser Davarzani, Gordon G A Hutchins, Nicholas P West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) ChemotherapyElizabeth Smyth, Shenli Zhang, David Cunningham, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Plos One|May 19, 2012
rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancerBríd M Ryan, Andrew C McClary, Nicola Valeri, et al.
Non-Coding RNA Research|December 12, 2018
LONG-NONCODING RNAs in gastroesophageal cancersGiuseppe Nicolò Fanelli, Pierluigi Gasparini, Irene Coati, et al.
Virchows Archiv : an International Journal of Pathology|December 23, 2023
Prevalence and type of MMR expression heterogeneity in colorectal adenocarcinoma: therapeutic implications and reportingFederica Grillo, Valentina Angerilli, Paola Parente, et al.
Clinical Colorectal Cancer|November 9, 2018
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center ExperienceKhurum Khan, Jayant K Rane, David Cunningham, et al.
Stem Cell Reports|January 20, 2023
USP7 inactivation suppresses APC-mutant intestinal hyperproliferation and tumor developmentLaura Novellasdemunt, Anna Kucharska, Anna Baulies, et al.
Oncotarget|December 25, 2015
Let-7c down-regulation in Helicobacter pylori-related gastric carcinogenesisMatteo Fassan, Deborah Saraggi, Laura Balsamo, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|June 5, 2026
Apparent diffusion coefficient and kurtosis parameters show early response to anti-angiogenic therapy in patients with colorectal liver metastasesMihaela Rata, Khurum Khan, David J Collins, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 17, 2010
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2)Nicola Valeri, Pierluigi Gasparini, Chiara Braconi, et al.
Histopathology|February 22, 2018
Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trialNasser Davarzani, Gordon G A Hutchins, Nicholas P West, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) ChemotherapyElizabeth Smyth, Shenli Zhang, David Cunningham, et al.
Pageof 10